A causal role for E-cadherin in the transition from adenoma to carcinoma
- PMID: 9515965
- DOI: 10.1038/32433
A causal role for E-cadherin in the transition from adenoma to carcinoma
Abstract
Development of malignant tumours is in part characterized by the ability of a tumour cell to overcome cell-cell adhesion and to invade surrounding tissue. E-cadherin is the main adhesion molecule of epithelia, and it has been implicated in carcinogenesis because it is frequently lost in human epithelial cancers. Re-establishing the functional cadherin complex in tumour cell lines results in a reversion from an invasive to a benign epithelial phenotype. However, it remained unresolved whether the loss of E-cadherin-mediated cell adhesion was a cause or a consequence of tumour progression in vivo. Here we report that the loss of E-cadherin expression coincides with the transition from well differentiated adenoma to invasive carcinoma in a transgenic mouse model of pancreatic beta-cell carcinogenesis (Rip1Tag2). Intercrossing Rip1Tag2 mice with transgenic mice that maintain E-cadherin expression in beta-tumour cells results in arrest of tumour development at the adenoma stage, whereas expression of a dominant-negative form of E-cadherin induces early invasion and metastasis. The results demonstrate that loss of E-cadherin-mediated cell adhesion is one rate-limiting step in the progression from adenoma to carcinoma.
Similar articles
-
Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling.Oncogene. 2007 Apr 5;26(16):2290-8. doi: 10.1038/sj.onc.1210029. Epub 2006 Oct 9. Oncogene. 2007. PMID: 17043652
-
Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.Clin Cancer Res. 2006 Mar 1;12(5):1479-86. doi: 10.1158/1078-0432.CCR-05-1519. Clin Cancer Res. 2006. PMID: 16533771
-
E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.Cancer Res. 2005 Mar 1;65(5):1783-91. doi: 10.1158/0008-5472.CAN-04-3399. Cancer Res. 2005. PMID: 15753375
-
E-cadherin-catenin cell-cell adhesion complex and human cancer.Br J Surg. 2000 Aug;87(8):992-1005. doi: 10.1046/j.1365-2168.2000.01513.x. Br J Surg. 2000. PMID: 10931041 Review.
-
Molecular mechanisms of invasion and metastasis during mouse skin tumour progression.Invasion Metastasis. 1994-1995;14(1-6):7-16. Invasion Metastasis. 1994. PMID: 7657534 Review.
Cited by
-
Using components of the vitamin D pathway to prevent and treat colon cancer.Nutr Rev. 2012 Dec;70(12):721-9. doi: 10.1111/j.1753-4887.2012.00522.x. Epub 2012 Oct 12. Nutr Rev. 2012. PMID: 23206285 Free PMC article. Review.
-
PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer.Cancer Med. 2015 Aug;4(8):1258-71. doi: 10.1002/cam4.463. Epub 2015 May 29. Cancer Med. 2015. PMID: 26033689 Free PMC article.
-
Detection of Carcinoma-Associated Fibroblasts Derived from Mesothelial Cells via Mesothelial-to-Mesenchymal Transition in Primary Ovarian Carcinomas.Cancers (Basel). 2024 Jul 29;16(15):2697. doi: 10.3390/cancers16152697. Cancers (Basel). 2024. PMID: 39123425 Free PMC article.
-
Phenotype switching in melanoma: implications for progression and therapy.Front Oncol. 2015 Feb 13;5:31. doi: 10.3389/fonc.2015.00031. eCollection 2015. Front Oncol. 2015. PMID: 25763355 Free PMC article. Review.
-
Sorafenib inhibits tumor growth and improves survival in a transgenic mouse model of pancreatic islet cell tumors.ScientificWorldJournal. 2012;2012:529151. doi: 10.1100/2012/529151. Epub 2012 Dec 27. ScientificWorldJournal. 2012. PMID: 23346016 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases